STOCK TITAN
  1. Home
  2. News
  3. SSKN

STRATA Skin Sciences Inc - SSKN STOCK NEWS

Welcome to our dedicated news page for STRATA Skin Sciences (Ticker: SSKN), a resource for investors and traders seeking the latest updates and insights on STRATA Skin Sciences.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect STRATA Skin Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of STRATA Skin Sciences's position in the market.

News
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
Rhea-AI Summary
<p>STRATA Skin Sciences, Inc. announces a 1-for-10 reverse stock split effective June 6, 2024, to meet Nasdaq's bid price requirement. Shareholders approved the split, and the stock will trade under the symbol SSKN with a new CUSIP number. The split aims to maintain compliance and ensure a unified impact on all stockholders.</p>
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
stock split
-
News
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
Rhea-AI Summary
STRATA Skin Sciences, Inc. will have its President and CEO, Dr. Dolev Rafaeli, present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference will take place from April 30 to May 2, 2024, at the Paris Hotel & Casino in Las Vegas, with Dr. Rafaeli's presentation scheduled for May 1, 2024, at 2:30 pm Pacific Time. Investors can also schedule one-on-one meetings with Dr. Rafaeli during the conference. Those unable to attend can access all company presentations on the conference event platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.89%
Tags
conferences
-
News
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
Rhea-AI Summary
STRATA Skin Sciences, Inc. renews exclusive distribution agreements in China and Japan, accounting for 46% of total international revenue in 2023. The agreements are for three years with minimum unit placements and/or purchases of XTRAC and VTRAC devices, enhancing visibility and growth opportunities outside the U.S.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
News
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announces financial results for Q4 and full-year 2023, showcasing revenue of $8.7 million in Q4 and $33.4 million for the full year. The company reported a net loss of $3.8 million in Q4 and $10.8 million for the full year, with a focus on strategic growth, product innovation, and market expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.04%
Tags
earnings
-
News
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Rhea-AI Summary
PECA Labs, a medical device company, receives an additional CE Mark for its exGraft family of vascular grafts, allowing for post-operative expansion up to 140 percent. The company also opens a new facility for polymer processing and appoints Jeffrey O’Donnell, Sr. as executive chairman.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none
-
News
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
Rhea-AI Summary
STRATA Skin Sciences, Inc. (SSKN) to release fourth quarter and full-year 2023 financial results on March 27, 2024. Conference call to discuss financial results and corporate update scheduled for 4:30 PM ET. Webcast available for future reference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
conferences earnings
News
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
Rhea-AI Summary
STRATA Skin Sciences, Inc. (SSKN) announces an initiative to expand insurance coverage for dermatologic treatments, focusing on vitiligo and atopic dermatitis. The company aims to increase patient access to advanced treatments and higher provider reimbursement rates through advocacy efforts and leveraging its patient database. Dr. Dolev Rafaeli emphasizes enhancing patient quality of life and ensuring access to essential care. STRATA is advocating for the expansion of CPT code coverage for phototherapy treatments, engaging with policymakers and patient advocacy societies to broaden access to XTRAC treatments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
none
-
News
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) successfully amends its credit and security agreement with MidCap Financial Trust, removing minimum revenue requirements for 2023 and introducing future financial covenants. This move enhances liquidity, financial flexibility, and aligns with the Company's business operations. The amendment supports operational and capital needs, enabling the company to advance its mission of delivering innovative dermatological solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
none
-
News
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference   
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced the presentation of a poster titled 'Pulsed Broadband Light with Vacuum Suction (Photopneumatic Therapy) and Needle Insert to Treat Acne' at the Maui Derm 2024 Meeting. The poster highlights the safety and efficacy of one treatment session using STRATA’s TheraClear®X technology for cystic and papular acne reduction. Majority of lesions demonstrated ≥50% clearing by 1-2 weeks, exceeding the criteria of ≥30% reduction in lesion size at two follow-up visits. The most frequently reported event was mild hyperpigmentation, while erythema, edema, and flaking were observed in ≤10% of lesions. The clinical evaluation continues to highlight the efficacy and safety of the TheraClear®X system for treating acne.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
conferences
News
STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has been granted a 180-day extension by Nasdaq to regain compliance with the minimum bid price rule. The company received a notification letter from Nasdaq regarding its noncompliance with the minimum closing bid price requirement and has until June 24, 2024, to meet the $1.00 per share bid price for 10 consecutive business days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
none
Stock SSKN logo
STRATA Skin Sciences Inc

Nasdaq:SSKN

SSKN Rankings

#5180 Ranked by Market Cap
#4120 Ranked by Stock Gains
N/A Ranked by Dividends

SSKN Stock Data

17.88M
11.94M
4.26%
67.01%
0.61%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Horsham

About SSKN

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.